4//SEC Filing
Schall Thomas J. 4
Accession 0001790340-26-000014
CIK 0001790340other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 9:17 AM ET
Size
4.9 KB
Accession
0001790340-26-000014
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Schall Thomas J.
Director
Transactions
- Purchase
Class A Common Stock
[F1]2026-01-15$4.67/sh+21,645$101,041→ 74,530 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.61 to $4.69. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall|2026-01-20
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001423084
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 9:17 AM ET
- Size
- 4.9 KB